It consists of the tripeptide Glycyl-L-Histidyl-L-Lysine (GHK) chelated with a copper(II) ion
Among IL-22based therapies, the most extensively investigated agent is F-652, a recombinant fusion protein
Traditional treatments (topical steroids, biologics, immunosuppressants) target these pathways directly
As both TB-500 and BPC-157 peptides appear to exhibit similar pharmacological potential, when blended together, the potential action of both may be maximized what would otherwise occur with one peptide, might occur at a better, faster rate when combined
Research institutions benefit from this guarantee structure as it provides flexibility for experimental planning and budget management
For the wider landscape, see our roundups of peptides studied for fat loss, longevity peptides, and popular peptide stacks